| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0019 | 0.9 |